BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32859066)

  • 1. Production of a Granulysin-Based, Tn-Targeted Cytolytic Immunotoxin Using Pulsed Electric Field Technology.
    Guerrero-Ochoa P; Aguilar-Machado D; Ibáñez-Pérez R; Macías-León J; Hurtado-Guerrero R; Raso J; Anel A
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32859066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-tumoral potential of a human granulysin-based, CEA-targeted cytolytic immunotoxin.
    Ibáñez-Pérez R; Guerrero-Ochoa P; Al-Wasaby S; Navarro R; Tapia-Galisteo A; De Miguel D; Gonzalo O; Conde B; Martínez-Lostao L; Hurtado-Guerrero R; Sanz L; Anel A
    Oncoimmunology; 2019; 8(11):1641392. PubMed ID: 31646080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel Carcinoembryonic Antigen (CEA)-Targeted Trimeric Immunotoxin shows significantly enhanced Antitumor Activity in Human Colorectal Cancer Xenografts.
    Lázaro-Gorines R; Ruiz-de-la-Herrán J; Navarro R; Sanz L; Álvarez-Vallina L; Martínez-Del-Pozo A; Gavilanes JG; Lacadena J
    Sci Rep; 2019 Aug; 9(1):11680. PubMed ID: 31406218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity and pharmacokinetics in mice of a recombinant immunotoxin containing a disulfide-stabilized Fv fragment.
    Reiter Y; Pai LH; Brinkmann U; Wang QC; Pastan I
    Cancer Res; 1994 May; 54(10):2714-8. PubMed ID: 8168102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen binding and cytotoxic properties of a recombinant immunotoxin incorporating the lytic peptide, melittin.
    Dunn RD; Weston KM; Longhurst TJ; Lilley GG; Rivett DE; Hudson PJ; Raison RL
    Immunotechnology; 1996 Sep; 2(3):229-40. PubMed ID: 9373315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production and characterization of recombinant 9 and 15 kDa granulysin by fed-batch fermentation in Pichia pastoris.
    Guo Y; Luan G; Shen G; Wu L; Jia H; Zhong Y; Li R; Li G; Shen Y; Sun J; Hu S; Xiao W
    Appl Microbiol Biotechnol; 2013 Sep; 97(17):7669-77. PubMed ID: 23224405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gigantoxin-4-4D5 scFv is a novel recombinant immunotoxin with specific toxicity against HER2/neu-positive ovarian carcinoma cells.
    Lv X; Zhang J; Xu R; Dong Y; Sun A; Shen Y; Wei D
    Appl Microbiol Biotechnol; 2016 Jul; 100(14):6403-6413. PubMed ID: 27063011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble Cytoplasmic Expression and Purification of Immunotoxin HER2(scFv)-PE24B as a Maltose Binding Protein Fusion.
    Park S; Nguyen MQ; Ta HKK; Nguyen MT; Lee G; Kim CJ; Jang YJ; Choe H
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical Studies of Granulysin-Based Anti-MUC1-Tn Immunotoxins as a New Antitumoral Treatment.
    Guerrero-Ochoa P; Ibáñez-Pérez R; Berbegal-Pinilla G; Aguilar D; Marzo I; Corzana F; Minjárez-Sáenz M; Macías-León J; Conde B; Raso J; Hurtado-Guerrero R; Anel A
    Biomedicines; 2022 May; 10(6):. PubMed ID: 35740244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo potential of recombinant granulysin against human melanoma.
    Al-Wasaby S; Guerrero-Ochoa P; Ibáñez-Pérez R; Soler R; Conde B; Martínez-Lostao L; Anel A
    Cancer Treat Res Commun; 2021; 27():100355. PubMed ID: 33770663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production and introduction of a novel immunotoxin based on engineered RNase A for inducing death to Her1-positive cell lines.
    Forouharmehr A; Nassiri M; Ghovvati Roudsari S; Javadmanesh A
    J Cell Physiol; 2020 May; 235(5):4679-4687. PubMed ID: 31663127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical evaluation of a recombinant anti-prostate specific membrane antigen single-chain immunotoxin against prostate cancer.
    Wolf P; Alt K; Wetterauer D; Bühler P; Gierschner D; Katzenwadel A; Wetterauer U; Elsässer-Beile U
    J Immunother; 2010 Apr; 33(3):262-71. PubMed ID: 20445346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction, expression, and characterization of an anti-tumor immunotoxin containing the human anti-c-Met single-chain antibody and PE38KDEL.
    Liu Z; Feng Z; Zhu X; Xu W; Zhu J; Zhang X; Fan Z; Ji G
    Immunol Lett; 2013 Jan; 149(1-2):30-40. PubMed ID: 23026237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new scfv-based recombinant immunotoxin against EPHA2-overexpressing breast cancer cells; High in vitro anti-cancer potency.
    Rezaie E; Amani J; Bidmeshki Pour A; Mahmoodzadeh Hosseini H
    Eur J Pharmacol; 2020 Mar; 870():172912. PubMed ID: 31926992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Convergent potency of internalized gelonin immunotoxins across varied cell lines, antigens, and targeting moieties.
    Pirie CM; Hackel BJ; Rosenblum MG; Wittrup KD
    J Biol Chem; 2011 Feb; 286(6):4165-72. PubMed ID: 21138845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic and antitumor activity of a recombinant immunotoxin composed of disulfide-stabilized anti-Tac Fv fragment and truncated Pseudomonas exotoxin.
    Reiter Y; Kreitman RJ; Brinkmann U; Pastan I
    Int J Cancer; 1994 Jul; 58(1):142-9. PubMed ID: 8014011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient targeting of CD13 on cancer cells by the immunotoxin scFv13-ETA' and the bispecific scFv [13xds16].
    Grieger E; Gresch G; Niesen J; Woitok M; Barth S; Fischer R; Fendel R; Stein C
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2159-2170. PubMed ID: 28669053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody engineering of recombinant Fv immunotoxins for improved targeting of cancer: disulfide-stabilized Fv immunotoxins.
    Reiter Y; Pastan I
    Clin Cancer Res; 1996 Feb; 2(2):245-52. PubMed ID: 9816166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulysin induces apoptotic cell death and cleavage of the autophagy regulator Atg5 in human hematological tumors.
    Aporta A; Catalán E; Galán-Malo P; Ramírez-Labrada A; Pérez M; Azaceta G; Palomera L; Naval J; Marzo I; Pardo J; Anel A
    Biochem Pharmacol; 2014 Feb; 87(3):410-23. PubMed ID: 24269628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dimethyl 2,2-dichlorovinyl phosphate (DDVP) markedly decreases the expression of perforin, granzyme A and granulysin in human NK-92CI cell line.
    Li Q; Nakadai A; Ishizaki M; Morimoto K; Ueda A; Krensky AM; Kawada T
    Toxicology; 2005 Sep; 213(1-2):107-16. PubMed ID: 16002202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.